DERM awarded Class III CE approval

DERM makes medical history as world’s first autonomous skin cancer detection system is approved for clinical decisions in Europe

The Class III CE marking under the European Medical Device Regulation (MDR) 2017/745 reflects the highest level of regulatory scrutiny and underlines DERM’s safety, accuracy and effectiveness in detecting cancer in patients without clinician review. al decisions on skin cancer without oversight marking a transformative era for global healthcare.

Read More
Jess' Story

Patient experience: Jess’ Story

In this personal account, Jess shares her experience of the Skin Analytics pathway, what happened after she noticed a lump that had changed and how she felt about AI assessing her skin lesion.

Read More
NHS Providers Autonomous AI Webinar

WEBINAR: Autonomous AI in action – Tackling NHS backlogs and improving patient outcomes in dermatology

This webinar will showcase real NHS stories and expert insights into how AI as a Medical Device (AIaMD) is transforming dermatology waitlists, improving patient outcomes, and delivering measurable value across trusts.

Hear from NHS colleagues at Chelsea and Westminster Hospital NHS Foundation Trust (CWFT) about how they’re using DERM, the world’s first autonomous AIaMD for dermatology.

Read More
NHS Providers Conference

NHS Providers Conference 2024

Session recording now available to watch! At this year’s NHS Providers Conference, NHS University Hospitals of Liverpool Group shared value seen, learnings and future plans following the implementation of DERM.

Read More
HSJ Awards 2024

HSJ Awards 2024

Last night we joined our partners, NHS Suffolk and North East Essex Integrated Care Board and Chelsea and Westminster Hospital NHS Foundation Trust to celebrate their nominations at the HSJ Awards 2024.

Read More
The Outpatients Transformation South Conference

The Outpatients Transformation South Conference 2024

Skin Analytics and University Hospitals Dorset NHS Foundation Trust share how the Trust implemented DERM to address rising urgent suspected skin cancer referrals, finite dermatology capacity and a patient population with high incidence rates of skin cancer.

Read More
Buckinghamshire Healthcare NHS Trust

New partner! Buckinghamshire Healthcare NHS Trust

With a 300% increase in urgent suspected skin cancer referrals since 2010 and 45-50 patients seen per day at the Skin Cancer Centre in Amersham Hospital, Buckinghamshire Healthcare NHS Trust implements DERM to address their increasing dermatology demand.

Read More
MelaNoMore DK speech

MelaNoMore Summer BBQ 2024

Yesterday evening, some of the Skin Analytics team attended the MelaNoMore Summer BBQ in Guildford. We were grateful to be invited back for a third time and given the opportunity to speak.

Read More
HSJ awards 2024

HSJ Awards 2024 – The Shortlist!

Chelsea and Westminster Hospital NHS Foundation Trust (CWFT) and NHS Suffolk and North East Essex Integrated Care Board (SNEE) have been shortlisted for the HSJ Awards 2024, recognising an outstanding contribution to healthcare and securing a place at the prestigious awards ceremony later this year.

Read More
AI Appreciation Day 2024

AI Appreciation Day 2024

It’s AI Appreciation Day so we’re celebrating the human behind our AI as a medical device – Dr Jack Greenhalgh, Skin Analytics’ AI Director.

Read More

Subscribe to our news updates

We won't spam
you, we promise.